Stoke Therapeutics, Inc. (STOK)

28.05 -0.65 (-2.26%) USD  |  NASDAQ  |  Jan 20, 14:21
More

Stoke Therapeutics Normalized Income (Quarterly)

Normalized Income (Quarterly) Chart

View Normalized Income (Quarterly) for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Income (Quarterly) Range, Past 5 Years

View Normalized Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Income (Quarterly) Benchmarks

View Normalized Income (Quarterly) Benchmarks
Start Trial
Biogen, Inc. Upgrade
Insmed, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade